NORD's
Washington Office
Read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.
|
|
|
The National Organization for Rare Disorders (NORD) web site, its databases,
and the contents thereof are copyrighted by NORD. No part of the NORD web
site, databases, or the contents may be copied in any way, including but not
limited to the following: electronically downloading, storing in a retrieval
system, or redistributing for any commercial purposes without the express
written permission of NORD. Permission is hereby granted to print one hard
copy of the information on an individual disease for your personal use,
provided that such content is in no way modified, and the credit for the
source (NORD) and NORD’s copyright notice are included on the printed copy.
Any other electronic reproduction or other printed versions is strictly
prohibited.
The information in NORD's Rare Disease Database is for educational purposes only. It
should never be used for diagnostic or treatment purposes. If you have questions regarding
a medical condition, always seek the advice of your physician or other qualified health
professional. NORD's reports provide a brief overview of rare diseases. For more specific
information, we encourage you to contact your personal physician or the agencies listed as
"Resources" on this report.
Copyright 2010
NORD is very grateful to Alisdair McNeill, MD, Specialist Registrar in Medical Genetics, Regional Clinical Genetics Unit, Birmingham Womens Hospital, UK, for assistance in the preparation of this report.
Synonyms of Aceruloplasminemia
- familial apoceruloplasmin deficiency
- hereditary ceruloplasmin deficiency
Disorder Subdivisions
General Discussion Aceruloplasminemia is a rare genetic disorder characterized by the abnormal accumulation of iron in the brain and various internal organs. Affected individuals develop neurological symptoms including cognitive impairment and movement disorders. Degeneration of the retina and diabetes may also occur. Symptoms usually become apparent during adulthood between 20 and 60 years of age. Aceruloplasminemia is caused by mutations of the ceruloplasmin (CP) gene. This mutation is inherited as an autosomal recessive trait.
Aceruloplasminemia is classified as a Neurodegenerative disorder with Brain Iron Accumulation (NBIA). NBIA are a group of rare inherited disorders characterized by iron accumulation in the brain. Aceruloplasminemia is also classified as an iron overload disorder.
Organizations related to Aceruloplasminemia
- Iron Disorders Institute
PO Box 675
Taylors SC 29687
Phone #: 864-292-1175
800 #: 888-565-4766
e-mail: info@irondisorders.org
Home page: http://www.irondisorders.org
- Iron Overload Diseases Association, Inc.
433 Westwind Drive
PO Box 15857 West Palm Beach Fl 33416-5857
Phone #: 561-586-8246
800 #: 866-768-8629
e-mail: iod@ironoverload.org
Home page: http://ironoverload.org
- NBIA Disorders Association
2082 Monaco Court
El Cajon CA 92019-4235
Phone #: 619-588-2315
800 #: --
e-mail: info@nbiadisorders.org
Home page: http://www.NBIAdisorders.org
|
|